Phoenix Malvestio Healthcare Products Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 19-12-2024
- Paid Up Capital ₹ 6.80 M
as on 19-12-2024
- Company Age 13 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 88.74%
(FY 2022)
- Profit -509.22%
(FY 2022)
- Ebitda -131.74%
(FY 2022)
- Net Worth -60.53%
(FY 2022)
- Total Assets 63.77%
(FY 2022)
About Phoenix Malvestio Healthcare Products
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 6.80 M, as per Ministry of Corporate Affairs (MCA) records.
Valiyaveetil Sashikumar and Smitha Sashikumar serve as directors at the Company.
- CIN/LLPIN
U33100TN2011PTC079676
- Company No.
079676
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Mar 2011
- Date of AGM
16 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Kanchipuram, Tamil Nadu, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Phoenix Malvestio Healthcare Products?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Valiyaveetil Sashikumar  | Director | 16-Mar-2011 | Current |
| Smitha Sashikumar | Director | 16-Mar-2011 | Current |
Financial Performance of Phoenix Malvestio Healthcare Products.
Phoenix Malvestio Healthcare Products Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 88.74% increase. The company also saw a substantial fall in profitability, with a 509.22% decrease in profit. The company's net worth observed a substantial decline by a decrease of 60.53%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Phoenix Malvestio Healthcare Products?
In 2019, Phoenix Malvestio Healthcare Products had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Phoenix Medical Systems Private LimitedActive 37 years 4 monthsValiyaveetil Sashikumar and Smitha Sashikumar are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Phoenix Malvestio Healthcare Products?
Phoenix Malvestio Healthcare Products has a workforce of 16 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Phoenix Malvestio Healthcare Products, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Phoenix Malvestio Healthcare Products's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
